v2.4.0.8
STOCKHOLDERS' DEFICIENCY (Tables)
12 Months Ended
Dec. 31, 2013
Stockholders Equity Note [Abstract]  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
The following assumptions were used in estimating the fair value of stock options granted during the years ended December 31, 2013 and 2012:
 
 
 
2013
 
 
2012
 
 
 
 
 
 
 
 
 
 
Weighted Average Exercise Price
 
$
0.37
 
 
$
1.62
 
Expected Life
 
 
2 years
 
 
 
2-5 years
 
Volatility
 
 
125.0
%
 
 
50.0
%
Dividend Yield
 
 
0
%
 
 
0
%
Risk-free interest rate
 
 
0.30% - 1.62
%
 
 
0.41
%
Weighted Average Grant Date Fair Value of Options Issued
 
$
0.37
 
 
$
1.70
 
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]
A summary of the Company’s options outstanding and exercisable is presented below:
 
 
 
 
 
 
 
Weighted
 
 
 
 
 
 
 
 
 
 
Average
 
 
 
 
 
 
 
 
Weighted
 
Remaining
 
 
 
 
 
 
 
 
Average
 
Contractual
 
Aggregate
 
 
 
Number of
 
Exercise
 
Life
 
Intrinsic
 
 
 
Shares
 
Price
 
(Years)
 
Value
 
Balance – January 1, 2012
 
-
 
-
 
-
 
 
 
 
Granted
 
2,000,000
 
1.62
 
5.18
 
 
 
 
Exercised
 
-
 
 
 
 
 
 
 
 
Cancelled
 
-
 
 
 
 
 
 
 
 
Balance – December 31, 2012
 
2,000,000
 
1.62
 
5.18
 
$
 
Granted
 
75,000
 
0.37
 
4.48
 
 
 
 
Exercised
 
-
 
 
 
 
 
 
 
 
Cancelled
 
1,262,500
 
1.57
 
-
 
 
 
 
Balance – December 31, 2013
 
812,500
 
1.58
 
3.04
 
$
 
Balance – December 31, 2013 (exercisable)
 
737,500
 
1.70
 
2.89
 
$
 
Schedule of Stockholders Equity Note, Warrants or Rights [Table Text Block]
The following table summarizes the Company’s warrant activity through December 31, 2013:
 
 
 
 
 
 
 
Weighted
 
 
 
 
 
 
 
 
 
Average
 
 
 
 
 
 
 
Weighted
 
Remaining
 
 
 
 
 
 
 
Average
 
Contractual
 
Aggregate
 
 
 
Number of
 
Exercise
 
Life
 
Intrinsic
 
 
 
Shares
 
Price
 
(Years)
 
Value
 
 
 
 
 
 
 
 
 
 
 
 
 
Warrants outstanding at January 1, 2012
 
2,320,000
 
$
1.00
 
2.96
 
 
 
 
Granted
 
309,900
 
$
1.00
 
3.78
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Warrants outstanding at December 31, 2012
 
2,629,900
 
$
1.00
 
3.06
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Granted
 
7,800,000
 
$
1.00
 
4.43
 
 
 
 
Expired
 
 
 
 
 
 
 
 
Exercised
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Warrants outstanding at December 31, 2013
 
10,429,900
 
$
1.00
 
4.08
 
$
 
Warrants outstanding at December 31, 2013 (exercisable)
 
10,429,900
 
$
1.00
 
4.08
 
$
 
Series B Preferred Stock [Member]
 
Stockholders Equity Note [Abstract]  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
The fair value of these warrants on the issuance date was calculated using a compound option model that includes characteristics of both a binomial lattice and the Black-Scholes formula with the following weighted average assumptions:
 
Dividend Yield
 
 
0.00
%
Volatility
 
 
95.00
%
Risk-free Interest Rate
 
 
0.66-0.72
%
Expected Lives
 
 
4.78 years
 
Weighted Average Fair Value per Warrant
 
 
0.25
%
Warrants Issued
 
 
309,900
 
Aggregate Grant Date Fair Value
 
$
83,673